Our pioneering SomaScan® assay is a game changer for your oncology research

The SomaScan assay is designed for sensitivity and specificity to detect low-abundant proteins, such as cytokines, to lead to your next breakthrough discovery.

The SomaScan® assay empowers discovery

Accelerate your biomarker discovery with sensitive detection of 7,000 proteins from a 55-μL sample.

Diagnostic

Identify unique cancer-specific protein biomarkers for future diagnostic indicators.

Prognostic

Monitor proteins over time for markers indicative of disease progression/regression.

Predictive

Reveal proteins that correlate with a cancer event for development of preventive measures.

Stratification

Define protein signatures that correlate with specific subtypes for use in therapeutic development.

Also available: SomaScan® panels for targeted data

Cytokines

168 analytes

Oncology

863 analytes

Download our tech note for the SomaScan® assay

Download Tech Note

Additional resources

See relevant publications in our interactive viewer

Review publications